openPR Logo
Press release

Pulmonary Dilation Balloon Market Global Industry Analysis and Forecast Till 2027

11-15-2017 06:59 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Pulmonary Dilation Balloon Market Global Industry Analysis

The pulmonary dilation balloon is a technique used in the treatment of pulmonary valve stenosis. Pulmonary valve stenosis is an abnormality in which there is some deformity on or in the vicinity of the pulmonary valve, and this abnormality slows the blood flow. The pulmonary valve is the valve that aids the blood flow from the heart to lungs. In most of the cases, pulmonary valve stenosis develops before the birth of the person. In adults, if present pulmonary valve stenosis is present as a complication of some other illness. Pulmonary valve stenosis can be treated by some other methods also, but pulmonary dilation balloon has emerged as the most favored option over the past few years.

Request For ToC @ https://www.futuremarketinsights.com/toc/rep-gb-3485

Pulmonary valve stenosis has emerged as a serious disease in the last few years. According to a report published on National Center for Biotechnology Information (NCBI) 7.5% - 9% diseases of all the congenital heart diseases is pulmonary valve stenosis. According to the data of CDC more than 40,000 children are born with congenital heart diseases in the U.S. alone. Other than this over 2million people in the U.S. are living with congenital heart diseases. This high prevalence of the disease illustrates the possibilities for the market of pulmonary dilation balloon.

Pulmonary Dilation Balloon Market: Drivers and Restraints

The major factors that are expected to drive the growth of the pulmonary dilation balloon market are an increase in the number of congenital heart diseases and early detection of the disease owing to the better medical facilities. Also, the minimally invasive method of pulmonary dilation balloon procedure is favoring its adoption over the conventional surgical methods. Pulmonary dilation balloon procedure also involves fewer complications and a success rate, thereby increasing the chances of market growth.

The major factors that can limit the growth of the pulmonary dilation balloon market are the complexity of the pulmonary valve stenosis in some patients that does not allow the use of pulmonary dilation balloon and demands surgical procedure.

Pulmonary Dilation Balloon Market: Overview

The market for pulmonary dilation balloon is expected to see higher growth in the forecast period due to the increase in the incidences of pulmonary valve stenosis in the past few years. The pulmonary dilation balloon is a procedure used to open up the blocked artery. The removal of the blockage helps in restoring the normal functionality of the artery and the valve, and thus pulmonary dilation balloon procedure is used in the treatment of pulmonary valve stenosis. The pulmonary dilation balloon is not as invasive as surgery, and this is one of the major reasons behind its success. But along with all these merits the major limitation that pulmonary dilation balloon procedure has, is the risk factors associated with the procedure in rare cases. But the long-term effects and the high success rate over powers the limitations of the pulmonary dilation balloon.

Pulmonary Dilation Balloon Market: Region-wise Outlook

North America and Europe are the most developed market in pulmonary dilation balloon due to the presence of the advanced healthcare infrastructure. Asia Pacific albeit has a higher number of pulmonary valve stenosis cases but the lack of awareness about pulmonary dilation balloon is responsible for the less usage of pulmonary dilation balloon in this region. Middle East and African countries are seeing an even less growth of the market due to lower GDP, but the growth is expected to increase worldwide due to high adoption rate.

Request For Report sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3485

Pulmonary Dilation Balloon Market: Key Market Participants

The key players of the market include Boston Scientific and Envaste Medical Instruments.

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Contact Us

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Dilation Balloon Market Global Industry Analysis and Forecast Till 2027 here

News-ID: 816953 • Views: 115

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Pulmonary

Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Pulmonary Fibrosis Market Professional Survey Report 2017
Global Pulmonary Fibrosis Market: Snapshot Pulmonary fibrosis belongs to the family of interstitial diseases that can lead to damage of the lungs. As the lung tissue becomes stiff and thickened, it interferes with a person’s ability to breathe. The scarring of lung tissues is associated with a multitude of factors. However, in most cases, the cause of the problem can’t be determined. This state is termed as idiopathic pulmonary fibrosis. While the
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
Latest Report: Global Pulmonary Hypertension Market
MarketResearchReports.Biz presents this most up-to-date research on "Pulmonary Hypertension-Pipeline Insights, 2017" DelveInsights, Pulmonary Hypertension-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Pulmonary Hypertension. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,